DocGo Inc. (NASDAQ:DCGO) Shares Acquired by Intech Investment Management LLC

Intech Investment Management LLC increased its stake in DocGo Inc. (NASDAQ:DCGO) by 76.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,834 shares of the company’s stock after purchasing an additional 14,247 shares during the quarter. Intech Investment Management LLC’s holdings in DocGo were worth $139,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in DCGO. Centiva Capital LP purchased a new position in DocGo in the third quarter valued at about $43,000. Royce & Associates LP purchased a new stake in shares of DocGo during the 4th quarter worth approximately $64,000. Victory Capital Management Inc. grew its holdings in shares of DocGo by 100.3% in the 3rd quarter. Victory Capital Management Inc. now owns 51,349 shares of the company’s stock worth $170,000 after acquiring an additional 25,714 shares during the period. SG Americas Securities LLC increased its stake in DocGo by 12.9% in the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock valued at $183,000 after purchasing an additional 4,905 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in DocGo by 151.1% during the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock worth $365,000 after purchasing an additional 66,097 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Trading Down 1.8 %

DocGo stock opened at $2.73 on Friday. The stock has a market cap of $278.41 million, a PE ratio of 9.75, a P/E/G ratio of 14.16 and a beta of 1.08. The stock has a 50-day moving average price of $4.06 and a 200 day moving average price of $3.92. DocGo Inc. has a 52 week low of $2.63 and a 52 week high of $5.68.

Analyst Ratings Changes

DCGO has been the topic of several research reports. Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and lowered their target price for the company from $5.00 to $2.85 in a report on Friday, February 28th. Needham & Company LLC lowered their price objective on shares of DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a research note on Friday, February 28th. Finally, Stifel Nicolaus cut their target price on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $4.89.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.